Adalimumab/etanerceptTuberculosis: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2013年 / 1434卷 / 1期

关键词：

D O I：

10.1007/s40278-013-0491-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：5 / 5

相关论文

共 50 条

[1] Adalimumab/etanerceptTuberculosis: 24 case reports
[J]. Reactions Weekly, 2017, 1662 (1) : 21 - 21
[2] Adalimumab/etanerceptTuberculosis: case report
[J]. Reactions Weekly, 2020, 1800 (1) : 17 - 17
[3] Adalimumab/infliximabHyperhidrosis: 2 case reports
[J]. Reactions Weekly, 2016, 1583 (1) : 39 - 39
[4] Adalimumab/infliximabTuberculosis: 2 case reports
[J]. Reactions Weekly, 2021, 1846 (1) : 14 - 14
[5] Adalimumab/etanerceptScabies: 2 case reports
[J]. Reactions Weekly, 2015, 1546 (1) : 17 - 17
[6] Adalimumab/infliximabLupus: 2 case reports
[J]. Reactions Weekly, 2011, 1361 (1) : 5 - 5
[7] Adalimumab/infliximabDermatomycoses: 2 case reports
[J]. Reactions Weekly, 2012, 1390 (1) : 6 - 6
[8] Adalimumab/etanerceptSarcoidosis?: 2 case reports
[J]. Reactions Weekly, 2010, 1290 (1) : 5 - 5
[9] Adalimumab/etanerceptAsthma: 2 case reports
[J]. Reactions Weekly, 2016, 1583 (1) : 37 - 37
[10] Adalimumab/golimumabThyroiditis: 2 case reports
[J]. Reactions Weekly, 2015, 1557 (1) : 20 - 20

← 1 2 3 4 5 →